Article
IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line.
Anticancer research - 1 Jan 2000
Vucenik I, Tantivejkul K, Zhang Z S, Cole K E, Saied I, Shamsuddin A M
Abstract excerpt
Hepatocellular carcinoma (HCC) is a common tumor world-wide with extremely poor prognosis. Recent studies have shown that inositol hexaphosphate (IP6), a naturally occurring carbohydrate, has novel anti-cancer function in various in vitro and in vivo models. The aim of this study was to assess whether IP6 could inhibit the growth of human hepatocellular carcinoma. We treated HepG2, a human liver cancer cell line...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.